Chris Picardo

Director/Board Member at Modulus Therapeutics, Inc.

Consumer Services

Commercial Services

Profile

Chris Picardo is currently working as a Director at Life Science Washington and Modulus Therapeutics, Inc. He completed his undergraduate degree from Williams College.

Chris Picardo active positions

Companies	Position	Start
Modulus Therapeutics, Inc. Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020.	Director/Board Member	-
Life Science Washington	Director/Board Member	2022-01-10

All active positions of Chris Picardo

Training of Chris Picardo

Williams College

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Chris Picardo's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Modulus Therapeutics, Inc. Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020.	Commercial Services
Life Science Washington